Revenue decreases in 2025 were primarily driven by the accounting treatment of deferred revenue from the 2023 YUTIQ license agreement rather than operational declines. Operating expenses increased to ...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...

Participate in Minnesota-based prosopagnosia research. In the Prosopagnosia and Visual Cognition Lab at Bethel University, Dr. Sherryse Corrow and her students study high-level visual processes—like ...

Think you know iOS inside out? Well, think again. Unlock your iPhone's full potential with these hidden tweaks.